Dow Jones Futures Fall As Meta Dives On Guidance; Chipotle Eyes Buy Point
By Ed Carson
NEWS
Caterpillar Earnings Due; Will Dow Heavyweight Crush It Again?
- The earthmoving giant is acting like it may be getting ready for another resounding beat when it reports Thursday.
- The stock is the No. 3 performer year to date among 30 Dow Jones components, with a 23% gain.
- Caterpillar benefits from the $1-trillion federal windfall boosing manufacturing, mining and infrastructure projects.
Showcase
Ken Blanchard Blazes A New Trail To Build Top Leaders
By Morey Stettner
Merck Rides Keytruda To A Beat-And-Raise Despite Diabetes Pullback
By Allison Gatlin
Meta Stock Slides Despite Q1 Earnings Beat. AI Costs Rising As Guidance Disappoints.
By Ryan Deffenbaugh
IBM Stock Falls After Q1 Report, Plans For $6.4B HashiCorp Deal
By Ryan Deffenbaugh
PI Stock: Impinj Delivers Beat-And-Raise Report
By Patrick Seitz
Medpace Stock Flirts With Breakout On Big Earnings Reversal
By Allison Gatlin
ServiceNow Earnings Beat, Guidance Light. Software Stock Falls
By Reinhardt Krause
LRCX Stock: Lam Research Returns To Earnings Growth
By Patrick Seitz
Boeing Earnings Better Than Feared; BA Stock Bounces
By Jed Graham
Indexes Mixed As Meta Crashes On Earnings; Tesla Jumps On Musk's 'Cheap Car' Target
By Vidya Ramakrishnan
AT&T Earnings, Free Cash Flow, Subscriber Adds Beat
By Reinhardt Krause
TECHNOLOGY
Google 'Cookie' Phaseout Delayed Again. Trade Desk Rises.
- Yet again, Alphabet will delay its phaseout of third-party internet tracking cookies used by the advertising industry.
- Trade Desk (TTD) stock rose on the news while Google stock was little changed.
- Advertisers use third-party cookies embedded in browsing software to follow users around the internet.
Showcase
STEEL STOCKS
Nucor, Cleveland-Cliffs Earnings Due; Will Key Support Hold For Steel Stocks?
JED GRAHAM
- Nucor, Cleveland-Cliffs and Steel Dynamics stocks all enjoyed breakouts in the first quarter.
- Their stock prices peaked at the end of March as steel prices ended the quarter on a stronger note.
Showcase
BIOTECH
Biogen Stock: Will The Leqembi, Skyclarys Beat Help Shares Reverse?
- Two of Biogen's newest drugs, Leqembi and Skyclarys, walloped first-quarter sales expectations on Wednesday.
- Leqembi, the Alzheimer's drug Biogen developed with Eisai (ESAIY), generated $19 million in sales in Q1.
- Skyclarys sales came in at $78 million, beating forecasts for $69 million.
Showcase
TECHNOLOGY
Boston Scientific Pops Into Buy Zones On Solid First-Quarter Report
- The medical technology company reported adjusted earnings of 56 per share on $3.86 billion in first-quarter sales.
- That topped consensus estimates of 51 cents a share.
- In premarket trading Wednesday, BSX stock jumped over 4%.
Showcase
TECHNOLOGY
Biden Signs TikTok Ban-Or-Sell. What It Means For Meta, Google, Oracle.
- President Biden on Wednesday signed into law a bill that would either force the sale of TikTok or ban the app.
- Banning the immensely popular app would be felt across the tech landscape — from Meta and Alphabet to Oracle.
- This may be just the beginning of a drawn-out battle. TikTok's leadership has pledged to challenge the law.
Showcase